What is the recommended prophylaxis for Spontaneous Bacterial Peritonitis (SBP)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Spontaneous Bacterial Peritonitis (SBP) Prophylaxis

Long-term norfloxacin 400 mg once daily is the first-choice prophylaxis for patients who have had an episode of SBP, with ciprofloxacin 500 mg daily being the primary alternative when norfloxacin is unavailable. 1

Indications for SBP Prophylaxis

Secondary Prophylaxis (Prior SBP)

  • All patients who survive an episode of SBP should receive indefinite antibiotic prophylaxis until liver transplantation or resolution of ascites due to the high recurrence rate (70% at 1 year) 1
  • Without prophylaxis, survival rates are poor (30-50% at 1 year, 25-30% at 2 years) 1

Primary Prophylaxis (No Prior SBP)

Primary prophylaxis should be initiated in patients with:

  • Low ascitic fluid protein (<1.5 g/dL) AND advanced liver disease (Child-Pugh score ≥9 with serum bilirubin >3 mg/dL, impaired renal function, or serum sodium <130 mEq/L) 1
  • Cirrhotic patients with acute gastrointestinal hemorrhage (short-term prophylaxis for 5-7 days) 2, 1

Recommended Prophylactic Regimens

First-Line Options

  • Norfloxacin 400 mg once daily - Most extensively studied regimen, reduces SBP recurrence from 68% to 20% 1

Alternative Options

  • Ciprofloxacin 500 mg once daily - Primary alternative when norfloxacin is unavailable 2, 1
  • Trimethoprim-sulfamethoxazole 800/160 mg daily - Alternative with similar efficacy to norfloxacin but potentially more adverse events 1
  • Rifaximin - Emerging evidence suggests possibly superior efficacy compared to norfloxacin (4% vs 14% 6-month recurrence rate) 2, 1

Special Considerations

Gastrointestinal Bleeding

  • All cirrhotic patients with ascites and acute GI hemorrhage should receive short-term antibiotic prophylaxis (5-7 days) 2, 1
  • This reduces infection rates, decreases rebleeding risk, and improves survival 1
  • This is the most frequently overlooked indication for SBP prophylaxis 3

Monitoring During Prophylaxis

  • Regular assessment of renal function every 1-3 months 1
  • Periodic cultures to detect resistant organisms 1
  • Monitor for adverse effects of antibiotics, including:
    • Fluoroquinolones: musculoskeletal and nervous system side effects
    • Trimethoprim-sulfamethoxazole: rash, hyperkalemia, bone marrow suppression 1

Antibiotic Resistance Concerns

  • Quinolone prophylaxis is less effective in patients colonized with multidrug-resistant organisms (MDRO) 2
  • Healthcare-associated and nosocomial SBP infections may require alternative antibiotic coverage 4

Liver Transplantation Evaluation

  • All patients who survive an episode of SBP should be considered for liver transplantation evaluation, as SBP represents a significant decompensating event with poor long-term prognosis 1

Common Pitfalls in SBP Prophylaxis

  • Underutilization of prophylaxis - studies show up to 62% of SBP cases could have been prevented with proper adherence to guidelines 3
  • Failure to recognize gastrointestinal hemorrhage as an indication for prophylaxis (44% of preventable cases) 3
  • Inadequate long-term outpatient prophylaxis after discharge - only one-third of SBP survivors receive appropriate prophylaxis 3
  • Overlooking high bilirubin levels (≥2.5 mg/dL) as an indication for prophylaxis 3

By following these evidence-based recommendations for SBP prophylaxis, clinicians can significantly reduce morbidity and mortality in patients with cirrhosis and ascites.

References

Guideline

Spontaneous Bacterial Peritonitis Prophylaxis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Potential preventability of spontaneous bacterial peritonitis.

Digestive diseases and sciences, 2011

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.